ArticleBMC medical genetics2013

Evaluation of the need for routine clinical testing of PALB2 c.1592delT mutation in BRCA negative Northern Finnish breast cancer families.

Maria Haanpää et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.